HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Familial erythrocytosis arising from a gain-of-function mutation in the HIF2A gene of the oxygen sensing pathway.

Abstract
A mutation of HIF-2 alpha has been detected in three generations of a family with erythrocytosis and the mutation co-segregated with the erythrocytosis phenotype. Functional studies revealed that Gly537Trp mutation would significantly impair the function of HIF-2 alpha thus leading to increased synthesis of Epo. In addition to VHL and PHD2 a further member of the oxygen sensing pathway, namely HIF-2 alpha,can be a cause of erythrocytosis. Furthermore, HIF-2 alpha plays an important role in the regulation of Epo production. Continued study of idiopathic cases of erythrocytosis with raised serum Epo will reveal whether HIF-2 alpha will be a major cause of erythrocytosis on par with VHL.
AuthorsMelanie J Percy
JournalThe Ulster medical journal (Ulster Med J) Vol. 77 Issue 2 Pg. 86-8 (May 2008) ISSN: 0041-6193 [Print] Northern Ireland
PMID18711622 (Publication Type: Journal Article, Review)
Chemical References
  • Basic Helix-Loop-Helix Transcription Factors
  • endothelial PAS domain-containing protein 1
  • DNA
  • Oxygen
Topics
  • Animals
  • Basic Helix-Loop-Helix Transcription Factors (blood, genetics)
  • DNA (genetics)
  • Erythrocytes (metabolism)
  • Genetic Predisposition to Disease
  • Humans
  • Mutation
  • Oxygen (metabolism)
  • Pedigree
  • Polycythemia (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: